Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study.

PubWeight™: 2.55‹?› | Rank: Top 2%

🔗 View Article (PMID 19877093)

Published in Arthritis Rheum on November 15, 2009

Authors

Mike J L Peters1, Vokko P van Halm, Alexandre E Voskuyl, Yvo M Smulders, Maarten Boers, Willem F Lems, Marjolein Visser, Coen D A Stehouwer, Jacqueline M Dekker, Giel Nijpels, Rob Heine, Ben A C Dijkmans, Michael T Nurmohamed

Author Affiliations

1: VU Medical Center, Amsterdam, The Netherlands.

Articles citing this

Rheumatoid Arthritis, Anti-Cyclic Citrullinated Peptide Positivity, and Cardiovascular Disease Risk in the Women's Health Initiative. Arthritis Rheumatol (2015) 2.07

Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort analysis. Arthritis Res Ther (2012) 1.57

Current view of glucocorticoid co-therapy with DMARDs in rheumatoid arthritis. Nat Rev Rheumatol (2010) 1.48

Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study. Arthritis Res Ther (2016) 1.40

Cardiovascular events in early RA are a result of inflammatory burden and traditional risk factors: a five year prospective study. Arthritis Res Ther (2011) 1.35

Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation, risk predictors and the impact of treatment. Rheumatology (Oxford) (2014) 1.34

Validated methods for assessment of subclinical atherosclerosis in rheumatology. Nat Rev Rheumatol (2012) 1.23

Rheumatoid arthritis and cardiovascular disease. Am Heart J (2013) 1.14

Cardiovascular screening in rheumatoid arthritis: a cross-sectional primary care database study. BMC Fam Pract (2013) 1.08

Cardiovascular complications of rheumatoid arthritis: assessment, prevention, and treatment. Rheum Dis Clin North Am (2010) 1.06

Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis. Ann Rheum Dis (2011) 0.95

Advances in the medical treatment of rheumatoid arthritis. Hand Clin (2011) 0.93

Cardiorheumatology: cardiac involvement in systemic rheumatic disease. Nat Rev Cardiol (2014) 0.91

Management of cardiovascular risk in patients with rheumatoid arthritis: evidence and expert opinion. Ther Adv Musculoskelet Dis (2013) 0.89

Abatacept improves whole-body insulin sensitivity in rheumatoid arthritis: an observational study. Medicine (Baltimore) (2015) 0.89

Cardiovascular disease prevalence in patients with inflammatory arthritis, diabetes mellitus and osteoarthritis: a cross-sectional study in primary care. BMC Musculoskelet Disord (2012) 0.85

Contractile, but not endothelial, dysfunction in early inflammatory arthritis: a possible role for matrix metalloproteinase-9. Br J Pharmacol (2012) 0.85

Higher rates and clustering of abnormal lipids, obesity, and diabetes mellitus in psoriatic arthritis compared with rheumatoid arthritis. Arthritis Care Res (Hoboken) (2014) 0.85

Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure. Heart Fail Clin (2014) 0.84

The risk of acute coronary syndrome in rheumatoid arthritis in relation to tumour necrosis factor inhibitors and the risk in the general population: a national cohort study. Arthritis Res Ther (2014) 0.84

Unresolved questions in rheumatology: motion for debate: the data support evidence-based management recommendations for cardiovascular disease in rheumatoid arthritis. Arthritis Rheum (2013) 0.83

Impact of body weight on the achievement of minimal disease activity in patients with rheumatic diseases: a systematic review and meta-analysis. Arthritis Res Ther (2016) 0.82

Rheumatoid arthritis is associated with reduced adiposity but not with unfavorable major cardiovascular risk factor profiles and enhanced carotid atherosclerosis in black Africans from a developing population: a cross-sectional study. Arthritis Res Ther (2013) 0.81

The 'Switch' study protocol: a randomised-controlled trial of switching to an alternative tumour-necrosis factor (TNF)-inhibitor drug or abatacept or rituximab in patients with rheumatoid arthritis who have failed an initial TNF-inhibitor drug. BMC Musculoskelet Disord (2014) 0.80

Mechanisms of endothelial dysfunction in rheumatoid arthritis: lessons from animal studies. Arthritis Res Ther (2014) 0.80

Classical cardiovascular disease risk factors associate with vascular function and morphology in rheumatoid arthritis: a six-year prospective study. Arthritis Res Ther (2013) 0.80

Perioperative all-cause mortality and cardiovascular events in patients with rheumatoid arthritis: comparison with unaffected controls and persons with diabetes mellitus. Arthritis Rheum (2012) 0.80

Cardiovascular risk management in patients with active ankylosing spondylitis: a detailed evaluation. BMC Musculoskelet Disord (2015) 0.79

The role of inflammation, the autonomic nervous system and classical cardiovascular disease risk factors on subendocardial viability ratio in patients with RA: a cross-sectional and longitudinal study. Arthritis Res Ther (2012) 0.79

The risk of comorbidity. Ann Rheum Dis (2012) 0.79

Cardiovascular case fatality in rheumatoid arthritis is decreasing; first prospective analysis of a current low disease activity rheumatoid arthritis cohort and review of the literature. BMC Musculoskelet Disord (2014) 0.78

Cardiovascular co-morbidity in patients with rheumatic diseases. Arthritis Res Ther (2011) 0.77

Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis. PLoS One (2014) 0.77

The increased cardiovascular risk in rheumatoid arthritis: when does it start? Arthritis Res Ther (2010) 0.77

Cardiovascular risk score in Rheumatoid Arthritis. Pak J Med Sci (2016) 0.77

An evaluation of rheumatology practitioner outreach clinics: a qualitative study. BMC Health Serv Res (2012) 0.77

Rheumatoid Arthritis and Incidence of Twelve Initial Presentations of Cardiovascular Disease: A Population Record-Linkage Cohort Study in England. PLoS One (2016) 0.76

Co-morbidity index in rheumatoid arthritis: time to think. Clin Rheumatol (2015) 0.76

Rheumatoid Arthritis Disadvantages Younger Patients for Cardiovascular Diseases: A Meta-Analysis. PLoS One (2016) 0.76

Longer durations of antitumour necrosis factor treatment are associated with reduced risk of cardiovascular events in patients with rheumatoid arthritis. RMD Open (2015) 0.76

Cardiovascular risk in rheumatoid arthritis: assessment, management and next steps. Ther Adv Musculoskelet Dis (2016) 0.76

Left ventricular function in treatment-naive early rheumatoid arthritis. Am J Cardiovasc Dis (2014) 0.75

Comparisons between comorbid conditions and health care consumption in rheumatoid arthritis patients with or without biological disease-modifying anti-rheumatic drugs: a register-based study. BMC Musculoskelet Disord (2016) 0.75

The increased cardiovascular risk in patients affected by autoimmune diseases: review of the various manifestations. J Clin Med Res (2015) 0.75

Managing cardiovascular risk in patients with inflammatory arthritis: practical considerations. Ther Adv Musculoskelet Dis (2016) 0.75

Whole body bone tissue and cardiovascular risk in rheumatoid arthritis. J Osteoporos (2014) 0.75

Confounding by indication probably distorts the relationship between steroid use and cardiovascular disease in rheumatoid arthritis: results from a prospective cohort study. PLoS One (2014) 0.75

Aortic VCAM-1: an early marker of vascular inflammation in collagen-induced arthritis. J Cell Mol Med (2016) 0.75

Association of the Charlson comorbidity index with renal outcome and all-cause mortality in antineutrophil cytoplasmatic antibody-associated vasculitis. Medicine (Baltimore) (2014) 0.75

Body composition in patients with rheumatoid arthritis is not different than healthy subjects. Eur J Rheumatol (2014) 0.75

Rheumatoid arthritis and diabetes mellitus: Two faces of one coin? Comment on the article by Peters et al. Arthritis Care Res (Hoboken) (2010) 0.75

Prevalence of Cognitive Impairment in Recently Diagnosed Type 2 Diabetes Patients: Are Chronic Inflammatory Diseases Responsible for Cognitive Decline? PLoS One (2015) 0.75

Serum Resistin Level and Progression of Atherosclerosis during Glucocorticoid Therapy for Systemic Autoimmune Diseases. Metabolites (2016) 0.75

The specialist physician's approach to rheumatoid arthritis in South Africa. Korean J Intern Med (2016) 0.75

Evaluation of Audiometric Test Results to Determine Hearing Impairment in Patients with Rheumatoid Arthritis: Analysis of Data from the Korean National Health and Nutrition Examination Survey. PLoS One (2016) 0.75

Risk for cardiovascular disease in Japanese patients with rheumatoid arthritis: a large-scale epidemiological study using a healthcare database. Springerplus (2016) 0.75

Comorbidities of rheumatoid arthritis: Results from the Korean National Health and Nutrition Examination Survey. PLoS One (2017) 0.75

Cardiovascular risk management in patients with inflammatory arthritis: what is good for the joint is good for the heart and vice versa! F1000 Med Rep (2010) 0.75

[Inflammation-related cardiovascular morbidity : Pathophysiology and therapy]. Z Rheumatol (2010) 0.75

Imaging atherosclerosis in rheumatoid arthritis: evidence for increased prevalence, altered phenotype and a link between systemic and localised plaque inflammation. Sci Rep (2017) 0.75

Articles by these authors

Gait speed and survival in older adults. JAMA (2011) 15.01

Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol (2007) 13.46

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update. Ann Rheum Dis (2013) 10.92

Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. Diabetes Care (2005) 8.94

Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care (2012) 7.83

Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum (2004) 7.79

The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study. J Gerontol A Biol Sci Med Sci (2006) 7.38

Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum (2004) 7.13

Prognostic value of usual gait speed in well-functioning older people--results from the Health, Aging and Body Composition Study. J Am Geriatr Soc (2005) 6.54

C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39

American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Arthritis Rheum (2011) 6.28

Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci (2006) 6.08

AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidemiol (2009) 6.00

COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum (2002) 5.57

Comparison of treatment strategies in early rheumatoid arthritis: a randomized trial. Ann Intern Med (2007) 5.05

Daily activity energy expenditure and mortality among older adults. JAMA (2006) 4.36

American College of Rheumatology/European League against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. Ann Rheum Dis (2011) 4.15

Sarcopenia: alternative definitions and associations with lower extremity function. J Am Geriatr Soc (2003) 4.02

Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis. N Engl J Med (2006) 3.80

Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA (2012) 3.67

Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trial. Lancet (2002) 3.67

Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein. Blood (2008) 3.65

Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care (2008) 3.54

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: results of a multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2006) 3.51

Longitudinal study of muscle strength, quality, and adipose tissue infiltration. Am J Clin Nutr (2009) 3.44

Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue. Am J Clin Nutr (2005) 3.40

Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. J Clin Endocrinol Metab (2005) 3.36

OMERACT: an international initiative to improve outcome measurement in rheumatology. Trials (2007) 3.29

Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus. Arch Intern Med (2009) 3.29

Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis. Arthritis Rheum (2006) 3.26

Incidence of retinoblastoma in children born after in-vitro fertilisation. Lancet (2003) 3.22

Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care (2005) 3.19

Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond) (2005) 3.13

Added value of physical performance measures in predicting adverse health-related events: results from the Health, Aging And Body Composition Study. J Am Geriatr Soc (2009) 3.12

Inflammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med (2006) 3.10

Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev (2006) 3.06

Trunk fat and leg fat have independent and opposite associations with fasting and postload glucose levels: the Hoorn study. Diabetes Care (2004) 3.02

The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis. Arthritis Rheum (2004) 2.99

Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. Atherosclerosis (2006) 2.95

Alternative definitions of sarcopenia, lower extremity performance, and functional impairment with aging in older men and women. J Am Geriatr Soc (2007) 2.94

Dietary protein intake is associated with lean mass change in older, community-dwelling adults: the Health, Aging, and Body Composition (Health ABC) Study. Am J Clin Nutr (2008) 2.81

Strength and muscle quality in a well-functioning cohort of older adults: the Health, Aging and Body Composition Study. J Am Geriatr Soc (2003) 2.76

Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol (2003) 2.74

Development of antidrug antibodies against adalimumab and association with disease activity and treatment failure during long-term follow-up. JAMA (2011) 2.73

Associations of hip and thigh circumferences independent of waist circumference with the incidence of type 2 diabetes: the Hoorn Study. Am J Clin Nutr (2003) 2.70

External validation of a measurement tool to assess systematic reviews (AMSTAR). PLoS One (2007) 2.70

Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab (2007) 2.68

Weight change and the conservation of lean mass in old age: the Health, Aging and Body Composition Study. Am J Clin Nutr (2005) 2.67

Clinical response to adalimumab: relationship to anti-adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis. Ann Rheum Dis (2007) 2.67

Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study. Circulation (2005) 2.66

Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus. Nat Genet (2010) 2.61

Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. BMJ (2010) 2.54

Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Ann Rheum Dis (2012) 2.54

Rheumatoid factor and antibodies to cyclic citrullinated Peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol (2002) 2.42

Association between physical and cognitive function in healthy elderly: the health, aging and body composition study. Neuroepidemiology (2005) 2.39

Inflammatory markers and incident mobility limitation in the elderly. J Am Geriatr Soc (2004) 2.29

Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study. Circulation (2003) 2.28

Disease-modifying antirheumatic drugs are associated with a reduced risk for cardiovascular disease in patients with rheumatoid arthritis: a case control study. Arthritis Res Ther (2006) 2.28

Comparison of the LASA Physical Activity Questionnaire with a 7-day diary and pedometer. J Clin Epidemiol (2004) 2.27

Accuracy of serologic tests and HLA-DQ typing for diagnosing celiac disease. Ann Intern Med (2007) 2.26

Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study. Diabetes Care (2005) 2.25

Adipocytokines and the metabolic syndrome among older persons with and without obesity: the InCHIANTI study. Clin Endocrinol (Oxf) (2010) 2.24

"Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet (2005) 2.24

Cost-utility analysis of treatment strategies in patients with recent-onset rheumatoid arthritis. Arthritis Rheum (2009) 2.24

[Summary of the multidisciplinary guideline on cardiovascular risk management (revision 2011)]. Ned Tijdschr Geneeskd (2012) 2.23

The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis. Arthritis Rheum (2004) 2.22

Physical activity, exercise, and inflammatory markers in older adults: findings from the Health, Aging and Body Composition Study. J Am Geriatr Soc (2004) 2.21

Outcomes from the Patient Perspective Workshop at OMERACT 6. J Rheumatol (2003) 2.20

Mild renal insufficiency is associated with increased cardiovascular mortality: The Hoorn Study. Kidney Int (2002) 2.18